Polymorphisms of homocysteine metabolism are associated with intracranial aneurysms

Cerebrovascular Diseases

Volumn 26, Issue 4, 2008, Pages 425-429

  Semmler, Alexander ^a   Linnebank, Michael ^a   Krex, Dietmar ^b   Götz, Anika ^c   Moskau, Susanna ^a   Ziegler, Andreas ^c   Simon, Matthias ^a,d  

^a UNIVERSITY OF BONN   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Homocysteine; Intracranial aneurysm; Polymorphism; Transcobalamin 2

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; DIHYDROFOLATE REDUCTASE; GLUTATHIONE TRANSFERASE P1; HOMOCYSTEINE; METHIONINE SYNTHASE; REDUCED FOLATE CARRIER; TRANSCOBALAMIN II;

ADULT; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADULT; CARRIER PROTEINS; CYSTATHIONINE BETA-SYNTHASE; FEMALE; FERREDOXIN-NADP REDUCTASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HOMOCYSTEINE; HUMANS; INTRACRANIAL ANEURYSM; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; TETRAHYDROFOLATE DEHYDROGENASE; TRANSCOBALAMINS;

EID: 51749117804     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000155638     Document Type: Article

References (31)

1. Brisman JL, Song JK, Newell DW: Cerebral aneurysms. N Engl J Med 2006;355:928-939.
2. Ruigrok YM, Rinkel GJ, Wijmenga C: Genetics of intracranial aneurysms. Lancet Neurol 2005;4:179-189.
3. Teasdale GM, Wardlaw JM, White PM, Murray G, Teasdale EM, Easton V: The familial risk of subarachnoid haemorrhage. Brain 2005;128:1677-1685.
4. Schievink WI, Schaid DJ, Michels VV, Piepgras DG: Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg 1995;83:426-429.
5. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD: Homocysteine and stroke: evidence on a causal link from Mendelian randomisation. Lancet 2005;365:224-232.
6. Strauss E, Waliszewski K, Gabriel M, Zapalski S, Pawlak AL: Increased risk of the abdominal aortic aneurysm in carriers of the MTHFR 677T allele. J Appl Genet 2003;44:85-93.
7. Arauz A, Hoyos L, Cantu C, Jara A, Martinez L, Garcia I, Fernandez ML, Alonso E: Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection. Cerebrovasc Dis 2007;24:210-214.
8. Yap S, Boers GH, Wilcken B, Wilcken DE, Brenton DP, Lee PJ, Walter JH, Howard PM, Naughten ER: Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol 2001;21:2080-2085.
9. Simon M, Franke D, Ludwig M, Aliashkevich AF, Koster G, Oldenburg J, Bostrom A, Ziegler A, Schramm J: Association of a polymorphism of the ACVRL1 gene with sporadic arteriovenous malformations of the central nervous system. J Neurosurg 2006;104:945-949.
10. Moskau S, Golla A, Grothe C, Boes M, Pohl C, Klockgether T: Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke 2005;36:5-8.
11. Linnebank M, Moskau S, Farmand S, Fliessbach K, Kolsch H, Bos M, Grothe C, Becker D, Harbrecht U, Pohl C, Wullner U, Klockgether T: Homocysteine and carotid intimamedia thickness in a German population: lack of clinical relevance. Stroke 2006;37:2840-2842.
12. Ziegler A, König IR: A Statistical Approach to Genetic Epidemiology: Concepts and Applications. Weinheim, Wiley-VCH, 2006.
13. Wellek S: Tests for establishing compatibility of an observed genotype distribution with Hardy-Weinberg equilibrium in the case of a biallelic locus. Biometrics 2004;60:694-703.
14. Steffens M, Lamina C, Illig T, Bettecken T, Vogler R, Entz P, Suk EK, Toliat MR, Klopp N, Caliebe A, Konig IR, Kohler K, Ludemann J, Diaz LA, Fimmers R, Lichtner P, Ziegler A, Wolf A, Krawczak M, Nurnberg P, Hampe J, Schreiber S, Meitinger T, Wichmann HE, Roeder K, Wienker TF, Baur MP: SNP-based analysis of genetic substructure in the German population. Hum Hered 2006;62:20-29.
15. Guo W, Romano J: A generalized Sidak-Holm procedure and control of generalized error rates under independence. Stat Appl Genet Mol Biol 2007;6:article3.
16. Afman LA, Lievers KJ, van der Put NM, Trijbels FJ, Blom HJ: Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet 2002;10:433-438.
17. Afman LA, van der Put NM, Thomas CM, Trijbels JM, Blom HJ: Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. QJM 2001;94:159-166.
18. Miller JW, Ramos MI, Garrod MG, Flynn MA, Green R: Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults. Blood 2002;100:718-720.
19. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP: Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999;99:3092-3095.
20. Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP: Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001;104:2569-2575.
21. Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, Munzel T: Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 2005;97:e53-e59.
22. Cooke JP: Asymmetrical dimethylarginine: the Uber marker? Circulation 2004;109:1813-1818.
23. Fukuda S, Hashimoto N, Naritomi H, Nagata I, Nozaki K, Kondo S, Kurino M, Kikuchi H: Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 2000;101:2532-2538.
24. Sadamasa N, Nozaki K, Hashimoto N: Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms. Stroke 2003;34:2980-2984.
25. Krex D, Fortun S, Kuhlisch E, Schackert HK, Schackert G: The role of endothelial nitric oxide synthase (eNOS) genetic variants in European patients with intracranial aneurysms. J Cereb Blood Flow Metab 2006;26:1250-1255.
26. O'Sullivan SE: What is the significance of vascular hydrogen sulphide (H2S)? Br J Pharmacol 2006;149:609-610.
27. Xu X, Gammon MD, Wetmur JG, Rao M, Gaudet MM, Teitelbaum SL, Britton JA, Neugut AI, Santella RM, Chen J: A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am J Clin Nutr 2007;85:1098-1102.
28. Johnson WG, Stenroos ES, Spychala JR, Chatkupt S, Ming SX, Buyske S: New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet A 2004;124:339-345.
29. Johnson WG, Scholl TO, Spychala JR, Buyske S, Stenroos ES, Chen X: Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor for preterm delivery. Am J Clin Nutr 2005;81:664-668.
30. Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RG: Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 1988;263:13602-13609.
31. Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP: A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000;70:310-315.